データなし
コード銘柄名
現在値変化額変化率出来高売買代金始値前日終値高値安値時価総額浮動株時価株式総数浮動株5日変化率10日変化率20日変化率60日変化率120日変化率250日変化率年初来配当利回売買回転率直近PER前年PER振幅業種
お気に入り
データなし
ABVC BioPharma Seeks To Revolutionize Mental Health Treatment With A Safe Prozac Alternative, Boasting A MADRS Score Reduction Of -13.21 From Baseline Over 6 Weeks With A Placebo-subtracted Difference Of -4.1
ABVC BioPharma Receives $200,000 Payment From OncoX BioPharma as Part of Strategic Licensing Agreement
ABVC BioPharma Secures $200,000 in First Cash Licensing Payment From Oncology Products Partner, Totaling $546,000 From Three Partners
ABVCバイオファーマ | 10-Q:Q3 2024 四半期報告書
ABVC BioPharma GAAP EPS of -$0.09
ABVC BioPharma 2Q Loss/Shr $0.09 >ABVC
データなし